Clinical A Nation-wide Registry of Peripartum Cardiomyopathy: Clinical Status in Turkey
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Ege University
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Pregnancy outcome
Study Overview
Brief Summary
Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.
Detailed Description
Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded.
The objectives of the study are:
To define the clinical status and clinical characteristics of PPCM in Turkey
To define the outcome of PPCM (short and long term)
To define the demographical and possible etiological factors
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient above 18 years of age
- •Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
- •Ejection fraction less than 45% documented with echocardiography
Exclusion Criteria
- •Patients with any other known cardiac pathology
Outcomes
Primary Outcomes
Pregnancy outcome
Time Frame: 5 months after delivery
mortality of the mother
Secondary Outcomes
No secondary outcomes reported
Investigators
Meral Kayikcioglu
Prof Dr
Ege University